Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| HCM | PRESS-RELEASE | bullish | 8/10 | HUTCHMED announced positive Phase III SAFFRON trial results showing savolitinib (ORPATHYS) plus osimertinib (TAGRISSO) s | Aug 16, 2026 |
| ADAG | INST-CLUSTER | neutral | 4/10 | Three institutional investors (Geode, UBS, and Renaissance Technologies) accumulated $1.2M in ADAG during Q2 2026, while | Aug 16, 2026 |
| PFE | COURT-RULING | neutral | 1/10 | The Eastern District of Pennsylvania dismissed a pro se product liability lawsuit against Pfizer (PFE) without prejudice | Aug 15, 2026 |
| AMGN | COURT-RULING | bullish | 7/10 | Amgen and other drug manufacturers won summary judgment in D.D.C. against HHS, invalidating HRSA's certification of 11 c | Aug 15, 2026 |
| TAK | COURT-RULING | neutral | 4/10 | Takeda won partial summary judgment in a New Jersey federal disability discrimination lawsuit brought by a former employ | Aug 15, 2026 |
| ALEC | INST-CLUSTER | mixed | 4/10 | Alector (ALEC) saw a mixed institutional cluster in Q2 2026: 8 buyers added $918K in net new positions (led by Panagora | Aug 15, 2026 |
| ABCL | INST-CLUSTER | bearish | 6/10 | AbCellera Biologics (ABCL) saw a mixed institutional cluster in Q2 2026: 5 buyers added $51.3M in new positions (dominat | Aug 15, 2026 |
| ASMB | INST-CLUSTER | neutral | 4/10 | Assembly Biosciences (ASMB) saw a strong institutional accumulation cluster in Q2 2026, with 6 buyers adding $25.8M in n | Aug 15, 2026 |
| AKTS | INST-CLUSTER | mixed | 4/10 | Aktis Oncology (AKTS) saw a mixed institutional cluster in Q2 2026, with 6 buyers adding $3.9M in net new positions (led | Aug 15, 2026 |
| CABA | INST-CLUSTER | bullish | 5/10 | A significant institutional cluster formed in Cabaletta Bio (CABA) during Q2 2026, with 15 buyers accumulating $66.0M in | Aug 15, 2026 |
| BBOT | INST-CLUSTER | bearish | 4/10 | BridgeBio Oncology Therapeutics (BBOT) saw a bearish institutional cluster in Q2 2026, with 4 sellers (including Morgan | Aug 15, 2026 |
| ARCT | INST-CLUSTER | bullish | 5/10 | Six institutional investors accumulated $1.1M net in ARCT during 2026-Q2, with all buyers and zero sellers, a clean dire | Aug 15, 2026 |
| ARTV | INST-CLUSTER | bullish | 6/10 | A strong institutional cluster formed in ARTV during 2026-Q2, with 6 mega-passive and asset-manager buyers accumulating | Aug 15, 2026 |
| SEPN | CLUSTER | bearish | 7/10 | Septerna insiders sold $40.2M in stock over a 7-day window, led by a $31.7M open-market sale by director/10% owner RA Ca | Aug 15, 2026 |
| AMRX | CLUSTER | mixed | 5/10 | Amneal Pharmaceuticals insiders sold $7.1M in stock over a 7-day window, including the EVP of Legal and an Executive VP, | Aug 15, 2026 |
| BCAX | CLUSTER | neutral | 5/10 | No summary provided | Aug 15, 2026 |
| DNTH | CLUSTER | neutral | 4/10 | Multiple Dianthus Therapeutics insiders, including CEO Marino and GC Veness, executed open-market sales totaling $3.15M | Aug 15, 2026 |
| JNJ | CLUSTER | neutral | 2/10 | JNJ CEO Joaquin Duato and EVP/Chief Legal Officer Elizabeth Forminard sold a combined $29.11M in open-market shares over | Aug 15, 2026 |
| MEDP | CLUSTER | neutral | 4/10 | Medpace CEO August Troendle sold $21.1M in stock over a 3-day window (Aug 10-12), with a director selling an additional | Aug 15, 2026 |
| TWST | CLUSTER | neutral | 4/10 | Multiple Twist Bioscience insiders, including CEO Emily Leproust, sold a combined $6.37M of stock over a 7-day window. T | Aug 15, 2026 |
| SLGL | INSIDER-BUY | neutral | 3/10 | Opaleye Management Inc., a 10% owner, purchased 951 shares of Sol-Gel Technologies at $71.50, totaling ~$68K. This is a | Aug 15, 2026 |
| CADL | INST-CLUSTER | neutral | 4/10 | A strong institutional cluster formed in CADL during Q2 2026, with 13 buyers accumulating $83.4M in net new positions (t | Aug 15, 2026 |
| DMAC | INST-CLUSTER | neutral | 3/10 | A mixed institutional cluster in DMAC for Q2 2026 shows 5 small buyers (net +$525K) versus 3 sellers (net -$579K), with | Aug 15, 2026 |
| BEAM | INST-CLUSTER | bullish | 5/10 | Eight institutional investors accumulated $59.7M in BEAM during Q2 2026, led by Morgan Stanley doubling its stake to $67 | Aug 15, 2026 |
| BDTX | INST-CLUSTER | neutral | 4/10 | Eight institutional investors, led by BlackRock, State Street, and Geode, collectively doubled or added to their BDTX po | Aug 15, 2026 |
| AMLX | INST-CLUSTER | bullish | 6/10 | A strong institutional cluster formed in AMLX during Q2 2026, with 11 buyers accumulating a net $76.7M in new positions | Aug 15, 2026 |
| ALXO | INST-CLUSTER | neutral | 4/10 | Six mega-passive institutional investors (BlackRock, State Street, Geode, JPMorgan, Morgan Stanley, Citigroup) collectiv | Aug 15, 2026 |
| ALMS | INST-CLUSTER | bullish | 6/10 | A strong institutional cluster of 9 buyers accumulated $186.9M in ALMS during Q2 2026, led by Fidelity doubling its posi | Aug 15, 2026 |
| ARDX | INST-CLUSTER | bullish | 4/10 | An institutional cluster for Ardelyx (ARDX) shows net bullish conviction in Q2 2026, with 5 buyers adding $3.4M in aggre | Aug 15, 2026 |
| DERM | INST-CLUSTER | mixed | 4/10 | Q2 2026 institutional cluster in DERM shows a mixed picture: Wasatch Advisors added $10.2M (+34%), while BlackRock, Stat | Aug 15, 2026 |